Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04141046 · ClinicalTrials.gov registry record · NA
LUPUS Brain: tACS to Target the Neurophysiology of Depression, Cognitive Deficits, and Pain in Patients With SLE
A NA study, sponsored by University of North Carolina, Chapel Hill.
- Terminated
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT04141046 is a NA study that was terminated before completion, run by University of North Carolina, Chapel Hill. The registered enrollment target is 4 participants.
The verdict
NCT04141046, a NA study, was terminated before completion, sponsored by University of North Carolina, Chapel Hill.
- TERMINATED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate the effects of a type of non-invasive transcranial alternating current stimulation (tACS) on patients diagnosed with systemic lupus erythematosus (SLE) who are experiencing depression. Targeting depression in patients with SLE may provide benefit to these patients, as there is a clear relationship between chronic pain and depression. The investigators propose that a tACS stimulation montage that was previously used in depression could be beneficial to patients with SLE, resulting in reduced depression symptoms, thus resulting in reduced chronic pain and cognitive difficulties.
Interventions
- DEVICE XCSITE100 Stimulator - Individualized theta-tACS
- DEVICE XCSITE100 Stimulator - Individualized alpha-tACS
- DEVICE XCSITE100 Stimulator - Active Sham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2019-01-01 |
| Est. Completion | 2023-09-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04141046
The ClinicalTrials.gov registry entry for NCT04141046 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which XCSITE100 Stimulator - Individualized theta-tACS is the first listed.
NCT04141046 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04141046 about?
NCT04141046 is a clinical study titled "LUPUS Brain: tACS to Target the Neurophysiology of Depression, Cognitive Deficits, and Pain in Patients With SLE". The purpose of this study is to investigate the effects of a type of non-invasive transcranial alternating current stimulation (tACS) on patients diagnosed with systemic lupus erythematosus (SLE) who are experiencing depression. Targeting depression in patients with SLE may provide benefit to these...
What is the current status of trial NCT04141046?
This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2019-01-01. Estimated completion is 2023-09-15.
What interventions are being tested in trial NCT04141046?
The interventions under investigation include: XCSITE100 Stimulator - Individualized theta-tACS (DEVICE), XCSITE100 Stimulator - Individualized alpha-tACS (DEVICE), XCSITE100 Stimulator - Active Sham (DEVICE).
Who is sponsoring clinical trial NCT04141046?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.